Pleased to share results of our discrete choice experiment of the influence of HIV on organ procurement and allocation in Australia #HIVAIDS2025 #healthequity #IDsky #HIVsky #TxIDsky #PhD

check out our review of donor-derived infections in heart & lung transplant recipients! was a pleasure working with @michaelisonmd.bsky.social on this! #TxID doi.org/10.1016/j.jh...

🔔 Did you miss our webinar? 👉 Immune Biomarkers for CMV Infection You can now watch the recording! Camille Kotton and Stefan Tullius interview Bradley Gardiner about his team’s groundbreaking research and @transplantation.bsky.social paper. Watch here 🔗 tts.org/august27

Dr. Robert (Bob) Rubin Transplant ID Award Recipient for 2025 is the amazing @kottonnelson.bsky.social !!! #TxID #MedEd @astinfo.bsky.social

pleased to share our latest study showing that absolute lymphocyte count and donor serostatus can predict CMV within R+ lung transplant recipients! journals.lww.com/transplantjo...

Submit your abstracts for the CMV symposium 2025 to be held in Sept near Frankfurt. Submission deadline is June 30. The top 3 abstracts will have travel and accommodation covered. Priority for excellent abstracts submitted by those earlier in their career. It will be a wonderful meeting! Join us!!

Pleased to present our subgroup analysis @TSANZ. Would IPC specific to the SOT cohort be valuable? Which HAIs/OIs should we monitor, and how do we build a national framework for success? @ncicancer.bsky.social #TxID #IDSky

@martinasester.bsky.social @sl3mk3.bsky.social @bradgardiner.bsky.social

join on the next TTS/TID CPC webinar this week! should be a great case www.tts.org/component/co...

Really pleased to share the newly released 4th international CMV in SOT consensus guidelines, was great to be involved! journals.lww.com/transplantjo...

The @thetxidjournal.bsky.social CPC group welcomes new members: @bradgardiner.bsky.social , Carlos Gomez and Maha Al Amri. We have great representation globally. We are excited to learn from you !

Got a cool #TxID case? Let @maricarmalinis.bsky.social know! See below for more details.

Day 3 of #Forbes2024 underway, more great cases!

Day 3 of #Forbes2024 underway! More great and challenging cases!

Thanks everyone for making day 1 of #Forbes2024 a success! Great case presentations from our registrars and words of wisdom from @kottonnelson.bsky.social on the importance of preventative interventions in immunosuppressed patients!

@kottonnelson.bsky.social giving a tour de force of CMV in #SOT. Fabulous 👏 having Prof Kotton visiting 🇦🇺 @austin_health. Looking forward to #ForbesWeek hosted by @bradgardiner.bsky.social! #TID